RIP140 (receptor-interacting protein 140) is a transcriptional corepressor that regulates diverse genes such as those responsive to hormones and involved in metabolic processes. The expression of RIP140 is regulated by multiple hormonal activities in adipose tissue and cancer cell lines. However, it is unclear whether and how RIP140 is regulated post-transcriptionally. Using 5 RACE (rapid amplification of 5 cDNA ends), we have identified a novel 5 splice variant of RIP140 mRNA in mouse brain and P19 cells. A target sequence for miRNA (microRNA) mir-346 was found in the 5 UTR (5 -untranslated region) of RIP140 mRNA; this miRNA is also expressed endogenously in mouse brain and P19 cells. Gainand loss-of-function studies demonstrated that mir-346 elevates RIP140 protein levels by facilitating association of its mRNA with the polysome fraction. Furthermore, the activity of mir-346 does not require Ago-2 (Argonaute 2). The expression of mir-346 enhances the gene repressive activity of RIP140. This is the first report demonstrating post-transcriptional regulation of RIP140 mRNA, involving the enhancing effect of a specific miRNA that targets RIP140's 5 UTR.
INTRODUCTION
RIP140 (receptor-interacting protein 140) is a widely known transcription co-regulator that modulates the activities of many nuclear receptors and transcription factors [1] . Its physiological functions have been demonstrated in a gene knockout animal model and cell line-based systems; these include roles in many metabolism-related processes such as gluconeogenesis, glycolysis, fatty acid oxidation and mitochondria biogenesis, as well as modulation of the expression of hormone target genes [2] [3] [4] [5] . In RIP140-null mice, numerous genes were expressed abnormally and appeared to contribute to the severe phenotype of these animals, particularly with regard to energy homoeostasis [6] . RIP140 expression at the transcriptional level has been studied extensively and has been found to be regulated by hormones such as androgens, retinoid, oestrogen and progestin [7] [8] [9] [10] [11] [12] [13] . Interestingly, several splice variants of RIP140 mRNA have been identified [7, 11] , but whether and how RIP140 expression is regulated post-transcriptionally remains unclear.
miRNAs (microRNAs) are a large family of single-stranded non-coding regulatory RNAs, 21-23 nucleotides in length, that control target gene expression by binding to their complementary mRNA sequences in the UTRs (untranslated regions). Most studies have found that miRNAs act through the 3 UTRs of target mRNAs, although further studies showed possible similar miRNA regulatory mechanisms acting on the 5 UTRs [14] [15] [16] . Nevertheless, there are still relatively few examples of 5 UTRtargeting miRNAs. In general, miRNAs halt mRNA translation and sometimes facilitate mRNA degradation, resulting in downregulation of proteins produced by the targeted mRNA [17] . The miRNA targeting RIP140 mRNA, mir-346, is produced from the second intron of the GRID1 (glutamate receptor ionotropic delta 1) gene, which has been implicated in schizophrenia susceptibility [18] . mir-346 also regulates other cellular processes, including carcinogenesis, inflammatory response and differentiation [19] [20] [21] . However, mir-346 has never been shown to regulate transcription factor expression.
The present study identifies a novel 5 splice variant of RIP140 mRNA from mouse brain and P19 cells, and finds a mir-346 target site in its 5 UTR. We also establish that mir-346 controls the protein levels of RIP140 without altering its mRNA levels. Furthermore, mir-346-induced elevation of RIP140 protein levels enhances RIP140's transrepression of gene regulation.
EXPERIMENTAL

Antibodies and reagents
Antibodies against actin, RIP140 and Ago-2 (Argonaute 2) were obtained from Santa Cruz Biotechnology (actin, sc-47778) and Abcam (RIP140, ab-42126; Ago-2, ab-32381). mir-346 mimic (5 -UGUCUGCCCGAGUGCCUGCCUCU), mir-346 inhibitor (5 -UGUCUGCCCGAGUGCCUGCCUCU) and RIP140-specific siRNA (small interfering RNA) were from Qiagen. Streptavidin beads were from New England Biolabs, and at-RA (all-trans retinoic acid) was from Sigma.
Animal experimentation
All experiments involving animals in the present study were approved by the University's Institutional Animal Care and Use Committee and conform to the regulatory standard. Anaesthetic procedures were performed by injecting 62.5 mg of ketamine and 12.5 mg of xylazine multiplied by animal weight (in g). The number of animals used and animal suffering during and after experiments were minimized throughout the study.
The 5 RACE was conducted according to the manufacturer's instructions (Invitrogen). Briefly, total RNA was extracted from C57BL/6 mouse brain and P19 cells with TRIzol ® reagent (Invitrogen). RT (reverse transcription) reactions were performed with a reverse primer (5 -CCTGATGCACATCAGAGCCAAGC-3 ) specific for the RIP140 coding sequence. PCR reactions were performed using the universal sense primer provided in the 5 RACE kit, and the PCR product was cloned and sequenced.
Plasmid constructs
A full-length RIP140 5 UTR reporter was constructed by amplifying the 5 UTR obtained from 5 RACE and cloning it into a HindIII/BglII-digested pGL3 promoter vector (Promega); deletion mutants were generated by amplifying shorter 5 UTRs and cloning them into the pGL3 vector. The sense primers used to amplify the three deletion mutants were 5 -CCAGGA-GGTGCGCAGTTGACTG-3 , 5 -GCGTTTGGTGAGCAACG-AAAG-3 and 5 -GCCTCTGAGCCCCTCGTCACTG-3 . A reporter with a mutation in the mir-346-targeted region was prepared with a site-directed mutagenesis kit (Stratagene) using the primer pair 5 -CATAGCAGAGGCTCAGGCTGA-GCGTCACGATACTGACGTGCGTTTGGTG-3 and 5 -CAC-CAAACGCACGTCAGTATCGTGACGCTCAGCCTGAGCCT-CTGCTATG-3 . The 5 UTR-containing Gal4-RIP140 was made by inserting the full-length RIP140 5 UTR into NheI-digested Gal4-RIP140 [22] .
In vitro transcription and RNA pulldown assays
In vitro transcription of mir-346 was performed with a MAXIscript T7 transcription kit (Ambion) using biotinlabelled UTP (Roche). Biotin-labelled mir-346 was mixed with streptavidin beads for 1 h and the beads were washed briefly with PBS. Untransfected or reporter-transfected P19 lysates were mixed with the beads for 1 h and washed three times with PBS. Bound RNA was recovered by adding TRIzol to the precipitated beads, followed by real-time RT-PCR.
Sucrose gradient sedimentation
This assay was performed as previously described in [23] with slight modification. In brief, since we wanted to focus on polysomal fractions and polysome-bound transcripts, a lower centrifugation speed [20 000 rev./min, rotor SW55T1 (Beckman), 120 min at 4
• C] was used in the present study to concentrate the usually spread polysomal fractions into two to three centredistributed fractions of the gradient. The mRNP (messenger ribonucleoprotein) fractions were outside the shown gradient fractions. For EDTA release controls, 25 mM EDTA was included into the cell lysis buffer.
Transfection, transactivation assays and reporter assays
Transfections and luciferase reporter assays were conducted as described previously [24] . Briefly, P19 or COS-1 cells were cultured in 24-well plates and transfected using Lipofectamine negative siRNA; Qiagen) or a pair of Ago-2 siRNAs (targeting sequences: AAGGGTAAAGTTTACCAAAGA and CACCAC-CGGGAGAACAATCAA) using Hyperfect transfection reagents (Qiagen). For reporter assays of transrepressive activity, cells were transfected with 150 ng of the Gal4-fused RIP140; for DR5 reporter assays, cells were transfected with 200 ng of reporter and 1 μM at-RA. In both cases, cells were transfected for 36 h and lysed, and luciferase and lacZ activities were determined.
Real-time RT-PCR and immunoblotting
RT was conducted using the Omniscript Reverse Transcription Kit (QIAGEN). Briefly, 2 μg of total RNA was used for one RT reaction with a random hexamer. After obtaining cDNA, real-time PCR was conducted as described [24] using a SYBR Green qPCR kit (Stratagene) and specific primer pairs as follows: α-actin, 5 -TGGCCTTAGGGTGCAGGG-3 and 5 -GTGGGCCGCTCTA-GGCACCA-3 ; mir-346, 5 -CTGTGTTGGGCGTCTGTCTG-3 and 5 -GAAGGAGCAGCTCTGCCCAG-3 ; RIP140, 5 -GAA-CATGACTCATGGAGAAGAG-3 and 5 -GAATCAGACAGCC-TCTTCCG-3 (used for detecting RIP140 in both mouse and monkey cells); RIP140, 5 -GGTGCGCAGTTGACTGAGGAG-3 and 5 -CGGGCAGAGATGCACTGTTAAC-3 (amplifying region covers mir-346 target region and therefore used for detecting RIP140 upon mir-346-mimic and mir-346-inhibitor transfection); and luciferase, 5 -CGGTTGGCAGAAGCTATGAAAGC-3 and 5 -CAGTCGATGTACACGTTCGTCAC-3 . To detect mir-346, the RT reaction was conducted with a miScript Reverse Transcription Kit and the quantitative PCR was conducted with a miScript SYBR Green PCR Kit and specific primer assay for mir-346. The immunoblotting was performed as described in [23] .
Statistical analyses
At least three experiments were conducted to obtain statistical results, presented as means+ − S.D. Data were analysed using the Student's t test, where P < 0.05 was considered to be significant. 
RESULTS
Identification of the 5 UTR of RIP140 mRNA from mouse brain
Previous studies showed that RIP140 transcripts contain four exons [11] and are detected in the brain [25] . However, initial attempts to obtain full-length RIP140 mRNA using the reported 5 UTR sequence of RIP140 failed to amplify RIP140 mRNA from mouse brain, suggesting that brain tissue might use a different mRNA isoform of the RIP140 5 UTR. This was confirmed when 5 RACE of RIP140 mRNA extracted from mouse brain was used to identify a novel 5 splice variant of RIP140 mRNA. This variant was present in P19 mouse embryonal carcinoma cells as well as in the brain ( Figure 1A ). This novel splice variant contains a new exon (exon 1) upstream, followed by three of the other previously identified [11] exons (exons 2, 3 and 4) ( Figure 1B) .
The RIP140 5 UTR enhances RIP140 expression
To determine the role of this novel 5 UTR in affecting protein production from the coding region, a full-length 5 UTR of the RIP140 mRNA was cloned into an SV40 (simian-virus-40) promoter-driven luciferase cassette with its ATG fused in-frame to the 5 UTR. The 5 UTR of RIP140 mRNA significantly elevated reporter activity 6-fold, relative to the control reporter (Figure 2A ).
Both reporters used the same promoter, and the mRNA levels from both reporters were similar (results not shown), suggesting that the difference in reporter activity was not caused by effects on transcription or mRNA stability. Sucrose gradient sedimentation assays were therefore performed for the control-or RIP140 5 UTR reporter-transfected P19 cells. As shown in Figure 2 (B, upper lefthand panel), the heavy polysomes were located in fractions 10-12. As shown in the upper right-hand panel of Figure 2 (B), RIP140 5 UTR reporter transcripts were enriched in these fractions, whereas the control reporter transcripts were distributed to the lighter fractions (8-10), indicating enhanced translation of the RIP140 5 UTR reporter. In the EDTA release control ( Figure 2B , lower panels), in which EDTA led to the shift of mRNAs from the polysome-bound fractions toward the lighter fractions, both reporter transcripts indeed moved to lighter fractions (8-10) confirming the polysome-bound RIP140 5 UTR reporter transcripts detected in the experiment without EDTA. Although polysomal and monosomal peaks were not entirely separated in this modified gradient due to centralization of the polysomal fractions, the reporter transcripts ( Figure 2B , right panels) were apparently distributed toward, or away from, the heavy polysomal fractions, depending upon whether the transcripts contained the 5 UTR of RIP140. This supported that the 5 UTR of RIP140 indeed played a role in keeping RNA templates to the heavy polysomal fractions. A series of mutants were then generated by systematically deleting various 5 -terminal sequences of the wild-type 5 UTR ( Figure 2C ). The activities of constructs with larger deletions (constructs c and d) were significantly lower than those of the parental wild-type sequence or the shorter deletion (constructs a and b), suggesting that a critical 113-base region elevates the activity of this reporter.
mir-346 does not affect RIP140 mRNA levels
Within the 113-base region identified in the deletion studies (i.e. the difference between constructs b and c shown in Figure 2C ), we identified a potential mir-346 target sequence ( Figure 3A) . Endogenous expression of mir-346 in mouse brain and P19 cells was detected by real-time RT-PCR. The negative control COS-1 cells were confirmed to lack mir-346, assessed by real-time RT-PCR ( Figure 3B , left-hand panel), but expressed comparable levels of actin mRNA ( Figure 3B, right-hand panel) . The ability of mir-346 to affect the abundance of RIP140 mRNA was assessed using P19 cells that express both RIP140 and mir-346 endogenously. Real-time RT-PCR of RIP140 showed that RIP140 mRNA levels were not affected in P19 cells transfected with either a mir-346 mimic or a mir-346 inhibitor ( Figure 3C ), indicating that mir-346 did not affect transcription or mRNA stability of RIP140.
mir-346 up-regulates RIP140 protein expression
The ability of mir-346 to affect RIP140 protein levels was also examined. Because high levels of mir-346 were detected in P19 cells, a mir-346 inhibitor was transfected into P19 cells and the endogenous expression of RIP140 protein was monitored by immunoblotting. Relative to actin expression, RIP140 protein production was reduced significantly by the mir-346 inhibitor ( Figure 4A) . Similarly, when an expression system was reconstituted in COS-1 cells using an RIP140 5 UTR-regulated luciferase reporter, expression of the full-length reporter was significantly elevated by transfecting the cells with the mir-346 mimic; transfection with the control reporter produced an insignificant response ( Figure 4B ). Sucrose gradient sedimentation assays were performed on P19 cells to determine whether mir-346 acted, at least partially, by translational activation. As shown in Figure 4 (C), in cells receiving mir-346 inhibitor, endogenous RIP140 transcripts were distributed away from the polysomal fractions (moved to fractions 7-9). The EDTA release control ( Figure 4C , lower panels) again reproducibly shifted RIP140 transcripts to lighter fractions (fractions 7-10). These results supported that mir-346 up-regulated RIP140 expression at the translational level.
To validate further the specificity of mir-346 association with RIP140 mRNA, an RIP140 5 UTR reporter mutated at four nucleotides in the mir-346-targeted region was generated ( Figure 5A ). The wild-type and mutant RIP140 reporters were then transfected into P19 cells for 30 h. Total cell lysates were mixed with streptavidin beads pre-incubated with in vitrotranscribed biotin-labelled mir-346. After washing, the pulleddown RNA was recovered from the beads and detected by real-time RT-PCR with luciferase-specific primers. The mutant reporter transcript was not pulled down by biotinylated mir-346 as efficiently as the wild-type transcript ( Figure 5A ). Furthermore, transfection with mir-346 inhibitor effectively reduced wildtype RIP140 5 UTR reporter activity in P19 cells expressing endogenous mir-346, but failed to reduce reporter activity in cells transfected with the mutated reporter ( Figure 5B ). Taken together, these data confirm that mir-346 up-regulates RIP140 protein expression by targeting the predicted site located in the 5 UTR of RIP140 mRNA.
To determine whether this unusual up-regulation by miRNA required the RISC (RNA-induced silencing complex), we applied specific siRNAs targeting a critical RISC component, Ago-2, and performed luciferase reporter assays using the RIP140 5 UTR reporter. Figure 6 shows that silencing Ago-2 slightly up-regulated the basal activity of the RIP140 5 UTR reporter, but failed to abolish the mir-346 inhibitor-induced down-regulation. The data indicated that mir-346 mediated up-regulation of RIP140 translation through a different pathway, possibly independent of the typical RISC.
mir-346 enhances RIP140 transrepressive activity
Finally, the effect of mir-346 on the biological activity of RIP140 (i.e. co-repression of gene expression) was assessed. A Gal4 DNA-binding domain was fused to RIP140, such that expression would be regulated by RIP140 s 5 UTR and its biological activity would be reflected in the Gal4-luciferase activity. This construct was then used to test the function of RIP140 regulated by its own 5 UTR in P19 cells. The transrepressive activity of RIP140 was neutralized by the addition of mir-346 inhibitor and activity was restored by introducing mir-346 mimic ( Figure 7A ), indicating the modulation of RIP140 repressive activity by mir-346.
We also examined the effect of mir-346 on nuclear receptor activity, which is known to be repressed by RIP140. A widely used DR5-type retinoic acid-responsive element from the RAR-β (retinoic acid receptor β) basal promoter was tested for reporter activity in P19 cells, with or without the mir-346 inhibitor [26] . Treatment with at-RA reproducibly activated DR5 reporter activity, and activity was enhanced further by the addition of mir-346 inhibitor ( Figure 7B ). This supports the notion that lowering the levels of endogenous RIP140 protein relieves the repression of hormone-targeted gene expression. Furthermore, knocking down endogenous RIP140 (i.e. reducing repressor levels) with siRNA increased both basal and at-RA-induced reporter activities. However, mir-346 inhibitor was no longer effective in further enhancing at-RA-induced reporter activity in RIP140-knockdown cells, thus confirming that regulation of protein expression by the mir-346 occurs specifically via its interaction with RIP140.
DISCUSSION
The present study demonstrates expression of RIP140 in brain tissue induced by a novel 5 splice variant. We also identified mir-346 as a novel regulatory component that elevates RIP140 protein levels by targeting a specific sequence within the 5 UTR of the RIP140 mRNA. The results further indicate that mir-346 might contribute to the transrepressive activity of RIP140. This is the first study showing post-transcriptional regulation of RIP140 mRNA, and provides new insight into the role of mir-346 in modulating the function of certain transcription regulators from a specific cellular background. The results also suggest a potential role for mir-346 in co-ordinating extensive gene regulatory networks to maintain the homoeostasis in hormonal responses and metabolism.
miRNA can enhance target mRNA expression through targeting mRNA 3 UTRs in cell-cycle-arrested cells [27, 28] , or by antagonizing other repressive components, thereby altering RNA structures of 5 UTRs of mRNA targets, such as the 5 TOP (5 -terminal oligopyrimidine tract) motif [14] . However, no known trans-or cis-elements were identified near the mir-346 target region, suggesting that certain regulatory components remain to be identified that might co-ordinate with mir-346 to regulate RIP140 protein levels. Furthermore, the effect triggered by mir-346 does not require Ago-2, the critical component known to mediate miRNA-guided mRNA cleavage or translational inhibition. To this end, several recent studies have shown miRNA-mediated translational regulation through Ago-independent pathways [29] [30] [31] . Our present finding of the novel action of mir-346, i.e. specifically up-regulating RIP140 translation in an Ago-2-independent manner, suggests that mir-346 might be added to this growing list of potential new forms of miRNAs. The exact mechanism underlying their actions would be an important subject for further studies.
The physiological role of RIP140 has been demonstrated in numerous studies. RIP140 mediates the expression of (A) Transrepressive assays measured the luciferase reporter activities of Gal4-luciferase (Luc) reporter co-transfected with Gal4-fused RIP140 and RIP140 5 UTR in the presence or absence of mir-346 inhibitor or mir-346 inhibitor plus mir-346 mimic. *P < 0.05. tk, thymidine kinase promoter. (B) Luciferase activity induced by the DR5 reporter transfected with at-RA, mir-346 inhibitor or RIP140 siRNA. *P < 0.05; # P > 0.05.
genes related to metabolism, cell differentiation and carcinogenesis. Previous studies identified multiple post-translational modifications of RIP140 that modulate its repressive activity with respect to fat metabolism in cells [32] [33] [34] [35] [36] . The present study identified another post-transcriptional regulatory mechanism that controls RIP140 protein levels and that might also regulate its biological activity post-transcriptionally. Others studies have identified two other potential promoters for the RIP140 gene [11] .
Transcripts from both of these promoters also are likely to be regulated by mir-346 because the mir-346-sensitive site resides in an exon common to all the splice variants. However, it remains unknown whether mir-346 is co-expressed with the various RIP140 mRNA isoforms in different tissues or cell types. Such coexpression (or lack thereof) could be important for the expression and biological activity of RIP140 in various cellular backgrounds. The roles and target genes of RIP140 in neuronal cells are largely unknown. Since mir-346 is produced from the GRID1 gene, it is tempting to speculate that GRID1 and RIP140's signalling pathway might be related and/or co-regulated. In a physiological context where the level of GRID1 is altered, such as in schizophrenia patients, RIP140 might contribute to, or be involved in, the activity of GRID1. A potential role for RIP140 in the nervous system would be an interesting subject for future studies.
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